nodes	percent_of_prediction	percent_of_DWPC	metapath
Flecainide—Convulsion—Triamcinolone—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Flecainide—Tachycardia—Prednisolone—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Flecainide—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Flecainide—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Flecainide—Hypertension—Triamcinolone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Flecainide—Hypertension—Methylprednisolone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Flecainide—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Flecainide—Myalgia—Triamcinolone—ankylosing spondylitis	0.00238	0.00238	CcSEcCtD
Flecainide—Pneumonia—Methotrexate—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Flecainide—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Flecainide—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Flecainide—Eye disorder—Prednisone—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Flecainide—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Flecainide—Flushing—Prednisone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Flecainide—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Flecainide—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Flecainide—Discomfort—Triamcinolone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Flecainide—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Flecainide—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Flecainide—Renal failure—Methotrexate—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Flecainide—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Flecainide—Immune system disorder—Prednisone—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Flecainide—Malaise—Betamethasone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Flecainide—Malaise—Dexamethasone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Flecainide—Oedema—Triamcinolone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Flecainide—Vertigo—Dexamethasone—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Flecainide—Vertigo—Betamethasone—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Flecainide—Syncope—Dexamethasone—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Flecainide—Syncope—Betamethasone—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Flecainide—Haematuria—Methotrexate—ankylosing spondylitis	0.00225	0.00225	CcSEcCtD
Flecainide—Shock—Triamcinolone—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Flecainide—Insomnia—Prednisolone—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Flecainide—Alopecia—Prednisone—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Flecainide—Shock—Methylprednisolone—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Flecainide—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Flecainide—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Flecainide—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Flecainide—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Flecainide—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Flecainide—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Flecainide—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Flecainide—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Flecainide—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Flecainide—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Flecainide—Convulsion—Dexamethasone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Flecainide—Convulsion—Betamethasone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Flecainide—Hypertension—Dexamethasone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Flecainide—Hypertension—Betamethasone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Flecainide—Myalgia—Dexamethasone—ankylosing spondylitis	0.00216	0.00216	CcSEcCtD
Flecainide—Myalgia—Betamethasone—ankylosing spondylitis	0.00216	0.00216	CcSEcCtD
Flecainide—Anxiety—Betamethasone—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Flecainide—Anxiety—Dexamethasone—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Flecainide—Discomfort—Betamethasone—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Flecainide—Discomfort—Dexamethasone—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Flecainide—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Flecainide—Pain—Prednisolone—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Flecainide—Vision blurred—Prednisone—ankylosing spondylitis	0.00208	0.00208	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Flecainide—Oedema—Dexamethasone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Flecainide—Oedema—Betamethasone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Flecainide—Insomnia—Triamcinolone—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Flecainide—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Flecainide—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Flecainide—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Flecainide—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Flecainide—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Flecainide—Visual impairment—Methotrexate—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Flecainide—Shock—Betamethasone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Flecainide—Shock—Dexamethasone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Flecainide—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Flecainide—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Flecainide—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Flecainide—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Flecainide—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Flecainide—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Flecainide—Tachycardia—Betamethasone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Flecainide—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Flecainide—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Flecainide—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Flecainide—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Flecainide—Malaise—Prednisone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Flecainide—Vertigo—Prednisone—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Flecainide—Eye disorder—Methotrexate—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Flecainide—Syncope—Prednisone—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Flecainide—Tinnitus—Methotrexate—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Flecainide—Anorexia—Betamethasone—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Flecainide—Anorexia—Dexamethasone—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Flecainide—Urticaria—Prednisolone—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Flecainide—Fatigue—Triamcinolone—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Flecainide—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Flecainide—Pain—Triamcinolone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Flecainide—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Flecainide—Hypotension—Dexamethasone—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Flecainide—Hypotension—Betamethasone—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Flecainide—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Flecainide—Convulsion—Prednisone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Flecainide—Hypertension—Prednisone—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Flecainide—Myalgia—Prednisone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Flecainide—Arthralgia—Prednisone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Flecainide—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Flecainide—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Flecainide—Anxiety—Prednisone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Flecainide—Alopecia—Methotrexate—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Flecainide—Insomnia—Dexamethasone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Flecainide—Insomnia—Betamethasone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Flecainide—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Flecainide—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Flecainide—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Flecainide—Discomfort—Prednisone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Flecainide—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Flecainide—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Flecainide—Urticaria—Triamcinolone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Flecainide—Urticaria—Methylprednisolone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Flecainide—Dysgeusia—Methotrexate—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Flecainide—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Flecainide—Oedema—Prednisone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Flecainide—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Flecainide—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Flecainide—Decreased appetite—Betamethasone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Flecainide—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Flecainide—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Flecainide—Fatigue—Betamethasone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Flecainide—Fatigue—Dexamethasone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Flecainide—Shock—Prednisone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Flecainide—Pain—Betamethasone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Flecainide—Pain—Dexamethasone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Flecainide—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Flecainide—Tachycardia—Prednisone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Flecainide—Skin disorder—Prednisone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Flecainide—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Flecainide—Vision blurred—Methotrexate—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Flecainide—Anorexia—Prednisone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Flecainide—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Flecainide—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Flecainide—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Flecainide—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Flecainide—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Flecainide—Malaise—Methotrexate—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Flecainide—Vertigo—Methotrexate—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Flecainide—Leukopenia—Methotrexate—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Flecainide—Urticaria—Betamethasone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Flecainide—Urticaria—Dexamethasone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Flecainide—Dizziness—Prednisolone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Flecainide—Asthenia—Triamcinolone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Flecainide—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Flecainide—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Flecainide—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Flecainide—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Flecainide—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Flecainide—Insomnia—Prednisone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Flecainide—Paraesthesia—Prednisone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Flecainide—Pruritus—Triamcinolone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Flecainide—Cough—Methotrexate—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Flecainide—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Flecainide—Convulsion—Methotrexate—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Flecainide—Dyspepsia—Prednisone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Flecainide—Arthralgia—Methotrexate—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Flecainide—Myalgia—Methotrexate—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Flecainide—Chest pain—Methotrexate—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Flecainide—Decreased appetite—Prednisone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Flecainide—Rash—Prednisolone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Flecainide—Dermatitis—Prednisolone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Flecainide—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Flecainide—Fatigue—Prednisone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Flecainide—Headache—Prednisolone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Flecainide—Discomfort—Methotrexate—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Flecainide—Constipation—Prednisone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Flecainide—Confusional state—Methotrexate—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Flecainide—Dizziness—Triamcinolone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Flecainide—Dizziness—Methylprednisolone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Flecainide—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Flecainide—Asthenia—Dexamethasone—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Flecainide—Asthenia—Betamethasone—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Flecainide—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Flecainide—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Flecainide—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Flecainide—Nausea—Prednisolone—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Flecainide—Pruritus—Dexamethasone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Flecainide—Pruritus—Betamethasone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Flecainide—Skin disorder—Methotrexate—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Flecainide—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Flecainide—Vomiting—Triamcinolone—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Flecainide—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Flecainide—Rash—Triamcinolone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Flecainide—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Flecainide—Anorexia—Methotrexate—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Flecainide—Rash—Methylprednisolone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Flecainide—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Flecainide—Urticaria—Prednisone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Flecainide—Headache—Triamcinolone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Flecainide—Headache—Methylprednisolone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Flecainide—Abdominal pain—Prednisone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Flecainide—Body temperature increased—Prednisone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Flecainide—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Flecainide—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Flecainide—Hypotension—Methotrexate—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Flecainide—Dizziness—Dexamethasone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Flecainide—Dizziness—Betamethasone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Flecainide—Insomnia—Methotrexate—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Flecainide—Nausea—Triamcinolone—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Flecainide—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Flecainide—Nausea—Methylprednisolone—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Flecainide—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Flecainide—Somnolence—Methotrexate—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Flecainide—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Flecainide—Vomiting—Betamethasone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Flecainide—Vomiting—Dexamethasone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Flecainide—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Flecainide—Rash—Betamethasone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Flecainide—Rash—Dexamethasone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Flecainide—Dermatitis—Betamethasone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Flecainide—Dermatitis—Dexamethasone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Flecainide—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Flecainide—Fatigue—Methotrexate—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Flecainide—Headache—Dexamethasone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Flecainide—Headache—Betamethasone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Flecainide—Asthenia—Prednisone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Flecainide—Pain—Methotrexate—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Flecainide—Pruritus—Prednisone—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
Flecainide—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Flecainide—Diarrhoea—Prednisone—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Flecainide—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Flecainide—Nausea—Dexamethasone—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Flecainide—Nausea—Betamethasone—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Flecainide—Urticaria—Methotrexate—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Flecainide—Dizziness—Prednisone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Flecainide—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Flecainide—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Flecainide—Vomiting—Prednisone—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Flecainide—Rash—Prednisone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Flecainide—Dermatitis—Prednisone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Flecainide—Headache—Prednisone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Flecainide—Asthenia—Methotrexate—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Flecainide—Nausea—Prednisone—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Flecainide—Pruritus—Methotrexate—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Flecainide—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Flecainide—Dizziness—Methotrexate—ankylosing spondylitis	0.000994	0.000994	CcSEcCtD
Flecainide—Vomiting—Methotrexate—ankylosing spondylitis	0.000956	0.000956	CcSEcCtD
Flecainide—Rash—Methotrexate—ankylosing spondylitis	0.000948	0.000948	CcSEcCtD
Flecainide—Dermatitis—Methotrexate—ankylosing spondylitis	0.000947	0.000947	CcSEcCtD
Flecainide—Headache—Methotrexate—ankylosing spondylitis	0.000942	0.000942	CcSEcCtD
Flecainide—Nausea—Methotrexate—ankylosing spondylitis	0.000893	0.000893	CcSEcCtD
